Estimation of copy number aberrations: Comparison of exome sequencing data with SNP microarrays identifies homozygous deletions of 19q13.2 and CIC in neuroblastoma

International Journal of Oncology

Volumn 48, Issue 3, 2016, Pages 1103-1116

  Fransson, Susanne ^a   Östensson, Malin ^a   Djos, Anna ^a   Javanmardi, Niloufar ^a   Kogner, Per ^b   Martinsson, Tommy ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Capicua; Genomic alterations; Neuroblastoma; Pediatric cancer

Indexed keywords

ARTICLE; CHROMOSOME; CHROMOSOME 19Q13.2; CIC GENE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; EXOME; FOLLOW UP; GENE DELETION; GENE IDENTIFICATION; GENE SEQUENCE; GOLD STANDARD; HUMAN; INVESTIGATIVE PROCEDURES; NEUROBLASTOMA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE; CHROMOSOME 19; COMPARATIVE GENOMIC HYBRIDIZATION; DNA MICROARRAY; DNA MUTATIONAL ANALYSIS; DNA SEQUENCE; GENE AMPLIFICATION; GENE DOSAGE; GENETICS; HOMOZYGOTE; SWEDEN; TUMOR CELL LINE;

CIC PROTEIN, HUMAN; REPRESSOR PROTEIN;

CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 19; COMPARATIVE GENOMIC HYBRIDIZATION; DNA MUTATIONAL ANALYSIS; EXOME; GENE AMPLIFICATION; GENE DELETION; GENE DOSAGE; HOMOZYGOTE; HUMANS; NEUROBLASTOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRESSOR PROTEINS; SEQUENCE ANALYSIS, DNA; SWEDEN;

EID: 84958977427     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2016.3349     Document Type: Article

References (22)

1. Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM, Faldum A, Hero B, Iehara T, Machin D, et al; INRG Task Force: The International Neuroblastoma Risk Group (INRG) classification system: An INRG Task Force report. J Clin Oncol 27: 289-297, 2009
2. Carén H, Kryh H, Nethander M, Sjöberg RM, Träger C, Nilsson S, Abrahamsson J, Kogner P and Martinsson T. High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset. Proc Natl Acad Sci USA 107: 4323-4328, 2010
3. Janoueix-Lerosey I, Schleiermacher G, Michels E, Mosseri V, Ribeiro A, Lequin D, Vermeulen J, Couturier J, Peuchmaur M, Valent A, et al. Overall genomic pattern is a predictor of outcome in neuroblastoma. J Clin Oncol 27: 1026-1033, 2009
4. Cetinkaya C, Martinsson T, Sandgren J, Träger C, Kogner P, Dumanski J, Díaz de Ståhl T and Hedborg F. Age dependence of tumor genetics in unfavorable neuroblastoma: arrayCGH profiles of 34 consecutive cases, using a Swedish 25-year neuroblastoma cohort for validation. BMC Cancer 13: 231, 2013
5. Combaret V, Iacono I, Bréjon S, Schleiermacher G, Pierron G, Couturier J, Bergeron C and Blay JY. Analysis of genomic alterations in neuroblastoma by multiplex ligation-dependent probe amplification and array comparative genomic hybridization: A comparison of results. Cancer Genet 205: 657-664, 2012
6. Ambros IM, Brunner B, Aigner G, Bedwell C, Beiske K, Bénard J, Bown N, Combaret V, Couturier J, Defferrari R, et al A multilocus technique for risk evaluation of patients with neuroblastoma. Clin Cancer Res 17: 792-804, 2011
7. Sathirapongsasuti JF, Lee H, Horst BA, Brunner G, Cochran AJ, Binder S, Quackenbush J and Nelson SF. Exome sequencingbased copy-number variation and loss of heterozygosity detection: Exome CNV. Bioinformatics 27: 2648-2654, 2011
8. Krumm N, Sudmant PH, Ko A, O'Roak BJ, Malig M, Coe BP, Quinlan AR, Nickerson DA and Eichler EE; NHLBI Exome Sequencing Project: Copy number variation detection and genotyping from exome sequence data. Genome Res 22: 1525-1532, 2012
9. Valdés-Mas R, Bea S, Puente DA, López-Otín C and Puente XS. Estimation of copy number alterations from exome sequencing data. PLoS One 7: e51422, 2012
10. Boeva V, Popova T, Bleakley K, Chiche P, Cappo J, Schleiermacher G, Janoueix-Lerosey I, Delattre O and Barillot E. Control-FREEC: A tool for assessing copy number and allelic content using next-generation sequencing data. Bioinformatics 28: 423-425, 2012
11. Carén H, Erichsen J, Olsson L, Enerbäck C, Sjöberg RM, Abrahamsson J, Kogner P and Martinsson T. High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: Four cases of homozygous deletions of the CDKN2A gene. BMC Genomics 9: 353, 2008
12. Chang WCJ, Allaire JJ, Xie Y and McPehrson J. Shiny: Web Application Framework for R. R package version 0.12.0. Rpackage version 0120 2015. https: //cran.r-project.org/web/packages/shiny/index.html. Accessed August 5, 2015
13. Hoefling H A Path Algorithm for the Fused Lasso Signal Approximator. J Comput Graph Stat 19: 984-1006, 2010
14. Molenaar JJ, Koster J, Zwijnenburg DA, van Sluis P, Valentijn LJ, van der Ploeg I, Hamdi M, van Nes J, Westerman BA, van Arkel J, et al. Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature 483: 589-593, 2012
15. Pandey GK, Mitra S, Subhash S, Hertwig F, Kanduri M, Mishra K, Fransson S, Ganeshram A, Mondal T, Bandaru S, et al. The risk-Associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiation. Cancer Cell 26: 722-737, 2014
16. Pugh TJ, Morozova O, Attiyeh EF, Asgharzadeh S, Wei JS, Auclair D, Carter SL, Cibulskis K, Hanna M, Kiezun A, et al. The genetic landscape of high-risk neuroblastoma. Nat Genet 45: 279-284, 2013
17. Sausen M, Leary RJ, Jones S, Wu J, Reynolds CP, Liu X, Blackford A, Parmigiani G, Diaz LA Jr, Papadopoulos N, et al. Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma. Nat Genet 45: 12-17, 2013
18. Boeva V, Zinovyev A, Bleakley K, Vert JP, Janoueix-Lerosey I, Delattre O and Barillot E. Control-free calling of copy number alterations in deep-sequencing data using GC-content normalization. Bioinformatics 27: 268-269, 2011
19. Jiménez G, Shvartsman SY and Paroush Z. The Capicua repressor-A general sensor of RTK signaling in development and disease. J Cell Sci 125: 1383-1391, 2012
20. Eisenreich S, Abou-El-Ardat K, Szafranski K, Campos Valenzuela JA, Rump A, Nigro JM, Bjerkvig R, Gerlach EM, Hackmann K, Schröck E, et al. Novel CIC point mutations and an exon-spanning, homozygous deletion identified in oligodendroglial tumors by a comprehensive genomic approach including transcriptome sequencing. PLoS One 8: e76623, 2013
21. Sjöblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, et al. The consensus coding sequences of human breast and colorectal cancers. Science 314: 268-274, 2006
22. Choi N, Park J, Lee JS, Yoe J, Park GY, Kim E, Jeon H, Cho Y M, Roh TY and Lee Y. miR-93/miR-106b/miR-375-CICCRABP1: A novel regulatory axis in prostate cancer progression. Oncotarget 6: 23533-23547, 2015